Keyu Li

1.8k total citations
54 papers, 762 citations indexed

About

Keyu Li is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Keyu Li has authored 54 papers receiving a total of 762 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 16 papers in Molecular Biology and 12 papers in Immunology. Recurrent topics in Keyu Li's work include Pancreatic and Hepatic Oncology Research (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Keyu Li is often cited by papers focused on Pancreatic and Hepatic Oncology Research (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Keyu Li collaborates with scholars based in China, United States and Japan. Keyu Li's co-authors include Xubao Liu, Chunlu Tan, Yonghua Chen, Ang Li, Lei Zheng, Nan Niu, Christopher L. Wolfgang, Anna M. Wu, Jianxin Wang and Hailun Gu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Keyu Li

48 papers receiving 755 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keyu Li China 17 360 276 184 179 71 54 762
Yingjie Nie China 16 291 0.8× 159 0.6× 260 1.4× 152 0.8× 58 0.8× 41 714
Ahmed Al‐Samadi Finland 18 269 0.7× 287 1.0× 203 1.1× 167 0.9× 77 1.1× 62 797
Helga Schachner Austria 12 293 0.8× 262 0.9× 144 0.8× 124 0.7× 84 1.2× 25 642
Yisheng Fang United States 16 296 0.8× 171 0.6× 67 0.4× 207 1.2× 87 1.2× 45 737
Lijun Mu China 15 398 1.1× 246 0.9× 373 2.0× 113 0.6× 147 2.1× 31 901
Yamin Zhang China 13 344 1.0× 139 0.5× 98 0.5× 139 0.8× 67 0.9× 26 561
Kristelle J. Capistrano United States 9 352 1.0× 315 1.1× 468 2.5× 194 1.1× 75 1.1× 16 931
Yinmo Yang China 16 443 1.2× 410 1.5× 149 0.8× 263 1.5× 92 1.3× 38 871
H. Mytrang United States 10 378 1.1× 353 1.3× 454 2.5× 190 1.1× 84 1.2× 14 963
Michal Sobecki France 9 221 0.6× 159 0.6× 215 1.2× 144 0.8× 72 1.0× 12 654

Countries citing papers authored by Keyu Li

Since Specialization
Citations

This map shows the geographic impact of Keyu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keyu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keyu Li more than expected).

Fields of papers citing papers by Keyu Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keyu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keyu Li. The network helps show where Keyu Li may publish in the future.

Co-authorship network of co-authors of Keyu Li

This figure shows the co-authorship network connecting the top 25 collaborators of Keyu Li. A scholar is included among the top collaborators of Keyu Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keyu Li. Keyu Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xun, Yang, et al.. (2025). Efficacy and Safety of Antifungal Medicines in the Treatment of Invasive Aspergillosis: A Network Meta-Analysis. Journal of College of Physicians And Surgeons Pakistan. 35(9). 1173–1179.
2.
3.
Niu, Nan, Keyu Li, Jun-Ke Wang, et al.. (2025). Chemotherapy in synergy with innate immune agonists enhances T cell priming for checkpoint inhibitor treatment in pancreatic cancer. Biomarker Research. 13(1). 21–21. 2 indexed citations
4.
5.
Zeng, Jia, et al.. (2025). Comparative effect of different corticosteroids in severe community-acquired pneumonia: a network meta-analysis. BMC Pulmonary Medicine. 25(1). 210–210. 1 indexed citations
6.
7.
Sun, Yingying, Xin Wang, Jinxiu Li, et al.. (2024). Systematic Analysis of DNA Demethylase Gene Families in Foxtail Millet (Setaria italica L.) and Their Expression Variations after Abiotic Stresses. International Journal of Molecular Sciences. 25(8). 4464–4464. 5 indexed citations
8.
Wang, Junke, Jie Yang, Amol Narang, et al.. (2024). Consensus, debate, and prospective on pancreatic cancer treatments. Journal of Hematology & Oncology. 17(1). 92–92. 39 indexed citations
9.
Sun, Wei‐Chih, Juan Fu, Keyu Li, et al.. (2024). Semaphorin 3D promotes pancreatic ductal adenocarcinoma progression and metastasis through macrophage reprogramming. Science Advances. 10(42). eadp0684–eadp0684. 6 indexed citations
10.
Li, Keyu, Wenhua Xue, Zhihua Lu, et al.. (2024). Tumor-derived exosomal ADAM17 promotes pre-metastatic niche formation by enhancing vascular permeability in colorectal cancer. Journal of Experimental & Clinical Cancer Research. 43(1). 59–59. 27 indexed citations
11.
Deng, Yanru, et al.. (2023). Advances in the treatment of hepatogenous diabetes: A review. Medicine. 102(46). e36068–e36068. 1 indexed citations
12.
Bangayan, Nathanael J., Liang Wang, Donghui Cheng, et al.. (2023). Dual-inhibitory domain iCARs improve the efficiency of the AND-NOT gate CAR T strategy. Proceedings of the National Academy of Sciences. 120(47). e2312374120–e2312374120. 29 indexed citations
13.
Li, Keyu, Liqin Liu, Daniel Santos, et al.. (2023). Abstract 2959: Novel CD38xCD3 bispecific IgM T cell engager, IGM-2644, potently kills multiple myeloma cells though complement and T cell dependent mechanisms. Cancer Research. 83(7_Supplement). 2959–2959. 1 indexed citations
14.
Chen, Jia, Zhiguo Zhou, Wenjing Pan, et al.. (2022). Immune repertoire sequencing reveals an abnormal adaptive immune system in COVID‐19 survivors. Journal of Medical Virology. 95(1). e28340–e28340. 6 indexed citations
15.
Xia, Tao, Keyu Li, Nan Niu, et al.. (2022). Immune cell atlas of cholangiocarcinomas reveals distinct tumor microenvironments and associated prognoses. Journal of Hematology & Oncology. 15(1). 37–37. 49 indexed citations
16.
Shi, Lei, Xianglong Kong, Keyu Li, et al.. (2022). Gut Microbiota Protected Against pseudomonas aeruginosa Pneumonia via Restoring Treg/Th17 Balance and Metabolism. Frontiers in Cellular and Infection Microbiology. 12. 856633–856633. 31 indexed citations
17.
Fujiwara, Kenji, Jing Hao, Brian Herbst, et al.. (2020). Correction: Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO+IPI: a systematic review and meta-analysis. Journal for ImmunoTherapy of Cancer. 8(2). e0779–6corr1. 1 indexed citations
18.
Li, Keyu, et al.. (2019). Prognosis of diacapitular condylar fractures: a multivariate analysis. British Journal of Oral and Maxillofacial Surgery. 57(10). 1019–1024. 6 indexed citations
19.
Li, Xiangping, Fang Huang, Jianguo Yin, et al.. (2016). GPR30 decreases with vascular aging and promotes vascular smooth muscle cells maintaining differentiated phenotype and suppressing migration via activation of ERK1/2. OncoTargets and Therapy. 9. 3415–3415. 8 indexed citations
20.
Li, Keyu, Richard Tavaré, Kirstin A. Zettlitz, et al.. (2014). Anti-MET ImmunoPET for Non–Small Cell Lung Cancer Using Novel Fully Human Antibody Fragments. Molecular Cancer Therapeutics. 13(11). 2607–2617. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yingjie Nie Breakdown of academic impact, for papers by Ahmed Al‐Samadi Breakdown of academic impact, for papers by Helga Schachner Breakdown of academic impact, for papers by Yisheng Fang Breakdown of academic impact, for papers by Lijun Mu Breakdown of academic impact, for papers by Yamin Zhang Breakdown of academic impact, for papers by Kristelle J. Capistrano Breakdown of academic impact, for papers by Yinmo Yang Breakdown of academic impact, for papers by H. Mytrang Breakdown of academic impact, for papers by Michal Sobecki
Rankless by CCL
2026